Trial
NCT04365868
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
Phase IITERMINATEDREGULATORYConfidence: MEDIUM
Sponsor
Galectin Therapeutics Inc.
Collaborators
—
Condition
Prevention of Esophageal Varices
Intervention
belapectin
Why stopped
Based on FDA feedback, Stage 1 of NAVIGATE was analyzed as a stand-alone trial. Study was not prematurely terminated for safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30